Please ensure Javascript is enabled for purposes of website accessibility Emerging Markets Fund - Janus Henderson Investors
For Institutional Investors in the US

Emerging Markets Fund Holdings

Full Portfolio Holdings

(As of February 29, 2024)

% OF INVESTMENTS
Taiwan Semiconductor Manufacturing Co Ltd 9.36
Samsung Electronics Co Ltd 8.56
HDFC Bank Ltd 3.51
AIA Group Ltd 2.95
Bharti Airtel Ltd 2.89
Wal-Mart de Mexico SAB de CV 2.79
BBB Foods Inc 2.67
Tencent Holdings Ltd 2.44
Telkom Indonesia Persero Tbk PT 2.37
MakeMyTrip Ltd 2.34
ICICI Bank Ltd 2.20
BYD Co Ltd 2.11
Becle SAB de CV 2.10
Full Truck Alliance Co Ltd (ADR) 2.03
Saudi Awwal Bank 1.99
H World Group Ltd 1.95
Grupo Financiero Banorte SAB de CV 1.93
New Horizon Health Ltd 1.88
SK Hynix Inc 1.83
Allegro.eu SA 1.81
Eicher Motors Ltd 1.78
3R PETROLEUM OLEO E GAS SA 1.75
Bank Negara Indonesia Persero Tbk PT 1.67
NU Holdings Ltd/Cayman Islands 1.62
BDO Unibank Inc 1.58
Vietnam Technological & Commercial Joint Stock Bank 1.58
HDFC Life Insurance Co Ltd 1.40
BGF retail Co Ltd 1.38
International Container Terminal Services Inc 1.37
Contemporary Amperex Technology Co Ltd 1.29
Globant SA 1.29
EPL Ltd 1.18
LWSA SA 1.18
ASMPT Ltd 1.17
MercadoLibre Inc 1.15
E Ink Holdings Inc 1.11
Shenzhen Inovance Technology Co Ltd 1.07
Legend Biotech Corp (ADR) 1.03
Shenzhen Mindray Bio-Medical Electronics Co Ltd 0.98
Structure Therapeutics Inc (ADR) 0.96
ZJLD Group Inc 0.96
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd 0.94
Syngene International Ltd 0.92
Accton Technology Corp 0.90
CITIC Securities Co Ltd 0.86
Angelalign Technology Inc 0.85
Zai Lab Ltd 0.83
Fertiglobe plc 0.70
KEI Industries Ltd 0.66
Kalyan Jewellers India Ltd 0.64
StarPower Semiconductor Ltd 0.47
Zhaoke Ophthalmology Ltd 0.20
API Holdings Ltd 0.08
Canbridge Pharmaceuticals Inc 0.06
Cash & Equivalents 4.68
Janus Henderson publishes this listing of securities held as of the most recently available disclosure period, which varies depending on the portfolio. Any portion of holdings may be excluded from publication when deemed in the best interest of the portfolio. Securities are reported at market value.
The portfolio data and its presentation here is based on the investment book of record and may differ from the accounting book of record and complete schedules of investments in regulatory filings due to differing accounting and reporting standards.